[Testosterone substitution therapy in prostate cancer].

Kaminsky, A; Sperling, H

[Testosterone substitution therapy in prostate cancer]. / Testosteronsubstitutionstherapie beim Prostatakarzinom.

Kaminsky, A; Sperling, H.

Affiliation

Kaminsky A; Klinik für Urologie, Kliniken Maria Hilf GmbH, Viersener Str. 450, 41063 Mönchengladbach, Deutschland. angelika.kaminsky@mariahilf.de

Urologe A ; 50(8): 977-84, 2011 Aug.

Article in De | MEDLINE | ID: mdl-21811932

Subject(s)

Andropause/drug effects; Hormone Replacement Therapy; Hypogonadism/drug therapy; Prostatic Neoplasms/physiopathology; Testosterone/administration & dosage; Adult; Aged; Aged, 80 and over; Contraindications; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local/chemically induced; Neoplasm Staging; Prostate-Specific Antigen/blood; Prostatectomy; Prostatic Neoplasms/pathology; Prostatic Neoplasms/radiotherapy; Prostatic Neoplasms/surgery; Quality of Life; Risk Factors; Testosterone/adverse effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Testosterone / Hormone Replacement Therapy / Andropause / Hypogonadism Type of study: Etiology_studies / Observational_studies / Prognostic_studies Aspects: Patient_preference Limits: Adult / Aged / Aged80 / Humans / Male / Middle aged Language: De Journal: Urologe A Year: 2011 Document type: Article Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google